000 | 01159 a2200313 4500 | ||
---|---|---|---|
005 | 20250515234050.0 | ||
264 | 0 | _c20100825 | |
008 | 201008s 0 0 eng d | ||
022 | _a1469-493X | ||
024 | 7 |
_a10.1002/14651858.CD008169.pub2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBatterink, Josh | |
245 | 0 | 0 |
_aSpironolactone for hypertension. _h[electronic resource] |
260 |
_bThe Cochrane database of systematic reviews _cAug 2010 |
||
300 |
_aCD008169 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Meta-Analysis; Review; Systematic Review | ||
650 | 0 | 4 |
_aAntihypertensive Agents _xadverse effects |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aSpironolactone _xadverse effects |
700 | 1 | _aStabler, Sarah N | |
700 | 1 | _aTejani, Aaron M | |
700 | 1 | _aFowkes, Curt T | |
773 | 0 |
_tThe Cochrane database of systematic reviews _gno. 8 _gp. CD008169 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/14651858.CD008169.pub2 _zAvailable from publisher's website |
999 |
_c20025722 _d20025722 |